Wilmington, Delaware-based DuPont de Nemours, Inc. (DD) provides technology-based materials and solutions in the United States and internationally. The company has a market cap of $19.3 billion and operates through two segments, Healthcare & Water Technologies and Diversified Industrials.
DD is expected to release its Q1 2026 earnings soon. Ahead of the event, analysts expect the company’s EPS to be $0.49 on a diluted basis, down 52.4% from $1.03 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.
For fiscal 2026, analysts project the company’s earnings per share to be $2.30, up 36.9% from $1.68 in fiscal 2025. Moreover, its EPS is expected to rise 9.1% year over year (YoY) to $2.51 in fiscal 2027.
DD stock has surged 95.9% over the past 52 weeks, outperforming the S&P 500 Index’s ($SPX) 29.4% rise and the State Street Basic Materials Select Sector SPDR ETF’s (XLB) 32.9% rise during the same time frame.
On Feb. 10, DD stock rose 5% following the release of its Q4 2025 earnings. The company’s net sales for the quarter remained flat, coming in at $1.7 billion; its full-year net sales rose 2% from the prior year’s quarter to $6.8 billion. Moreover, DD’s adjusted EPS for the quarter rose 18% from its year-ago value to $0.46 and came in on top of the Wall Street estimates. For the full year, the company expects its net sales and adjusted EPS to be in the range of $7 billion to $7.1 billion and $2.25 to $2.30, respectively.
Analysts are highly bullish on DD, with the stock having a “Strong Buy” rating overall. Among the 15 analysts covering the stock, 12 are recommending a “Strong Buy,” one suggests a “Moderate Buy,” and two suggest a “Hold.” DD’s average analyst price target of $55.64 indicates an upside of 17.8% from current levels.
